Cargando…

NSAID Exposure and Risk of Alzheimer's Disease: An Updated Meta-Analysis From Cohort Studies

Background: Initial observational studies and a systematic review published recently have suggested that non-steroidal anti-inflammatory drug (NSAID) use has the trend to be associated with reduced risk of Alzheimer's disease (AD), while results remain conflicting. Thus, we performed an updated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Caixia, Wang, Yan, Wang, Dongyin, Zhang, Jidong, Zhang, Fangfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882872/ https://www.ncbi.nlm.nih.gov/pubmed/29643804 http://dx.doi.org/10.3389/fnagi.2018.00083

Ejemplares similares

NSAIDs: How they Work and their Prospects as Therapeutics in Alzheimer's Disease
por: Sastre, Magdalena, et al.
Publicado: (2010)

Association of inflammatory bowel disease and related medication exposure with risk of Alzheimer's disease: An updated meta-analysis
por: Xing, Yinghao, et al.
Publicado: (2023)

Are NSAIDs Useful to Treat Alzheimer's Disease or Mild Cognitive Impairment?
por: Imbimbo, Bruno P., et al.
Publicado: (2010)

Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis
por: Wang, Qianwen, et al.
Publicado: (2021)

Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis
por: Cui, Lei, et al.
Publicado: (2020)

Inflammatory bowel disease and risk of dementia: An updated meta-analysis
por: Liu, Nanyang, et al.
Publicado: (2022)

Experimental Evidence of the Benefits of Acupuncture for Alzheimer's Disease: An Updated Review
por: Yu, Chao-Chao, et al.
Publicado: (2020)

Pesticide exposure and risk of Alzheimer’s disease: a systematic review and meta-analysis
por: Yan, Dandan, et al.
Publicado: (2016)

Age Matching Is Essential for the Study of Cerebrospinal Fluid sTREM2 Levels and Alzheimer’s Disease Risk: A Meta-Analysis
por: Hu, Shimin, et al.
Publicado: (2021)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
por: Zhao, Juanjuan, et al.
Publicado: (2017)

Fusobacterium nucleatum infection-induced neurodegeneration and abnormal gut microbiota composition in Alzheimer’s disease-like rats
por: Yan, Caixia, et al.
Publicado: (2022)

The Association Between Folate and Alzheimer's Disease: A Systematic Review and Meta-Analysis
por: Zhang, Xiaohong, et al.
Publicado: (2021)

Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer’s Disease
por: Cacciatore, Ivana, et al.
Publicado: (2016)

25-Hydroxyvitamin D Levels and the Risk of Dementia and Alzheimer's Disease: A Dose–Response Meta-Analysis
por: Chen, Hanze, et al.
Publicado: (2018)

Alzheimer’s Disease: An Update and Insights Into Pathophysiology
por: Abubakar, Murtala Bello, et al.
Publicado: (2022)

Relationship Between Alzheimer’s Disease and the Immune System: A Meta-Analysis of Differentially Expressed Genes
por: Wang, Nan, et al.
Publicado: (2019)

NSAIDs May Protect Against Age-Related Brain Atrophy
por: Bendlin, Barbara B., et al.
Publicado: (2010)

Use of NSAIDs via the Rectal Route for the Prevention of Pancreatitis after ERCP in All-Risk Patients: An Updated Meta-Analysis
por: Yu, Lei-Min, et al.
Publicado: (2018)

An update on mobile applications collecting data among subjects with or at risk of Alzheimer's disease
por: Piendel, Lydia, et al.
Publicado: (2023)

Diclofenac reduces the risk of Alzheimer’s disease: a pilot analysis of NSAIDs in two US veteran populations
por: Stuve, Olaf, et al.
Publicado: (2020)

Mechanisms Underlying Neuroprotection by the NSAID Mefenamic Acid in an Experimental Model of Stroke
por: Khansari, Parto S., et al.
Publicado: (2019)

Association of Peripheral Blood Cell Profile With Alzheimer's Disease: A Meta-Analysis
por: Huang, Le-Tian, et al.
Publicado: (2022)

Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease
por: Yan, Xu, et al.
Publicado: (2020)

Effectiveness of Physical Activity Interventions on Cognition, Neuropsychiatric Symptoms, and Quality of Life of Alzheimer’s Disease: An Update of a Systematic Review and Meta-Analysis
por: Liang, Ya-Jing, et al.
Publicado: (2022)

Low-Density Lipoprotein Cholesterol and Alzheimer's Disease: A Systematic Review and Meta-Analysis
por: Zhou, Zhike, et al.
Publicado: (2020)

Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer's Disease: A Meta-Analysis of Case-Control Studies
por: Li, Dan-Dan, et al.
Publicado: (2017)

The Diagnostic Value of Exosome-Derived Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment: A Meta-Analysis
por: Xing, Wenmin, et al.
Publicado: (2021)

Chemokines in patients with Alzheimer's disease: A meta-analysis
por: Wang, Hecheng, et al.
Publicado: (2023)

Selenium Exposure and Cancer Risk: an Updated Meta-analysis and Meta-regression
por: Cai, Xianlei, et al.
Publicado: (2016)

Economic evaluation of the screening for Alzheimer’s disease in China
por: Ren, Yinan, et al.
Publicado: (2022)

Prolong Exposure of NSAID in Patients With RA Will Decrease the Risk of Dementia: A Nationwide Population-Based Cohort Study
por: Chang, Kuang-Hsi, et al.
Publicado: (2016)

Network meta-analysis of migraine disorder treatment by NSAIDs and triptans
por: Xu, Haiyang, et al.
Publicado: (2016)

Vitamin D deficiency as a risk factor for dementia and Alzheimer’s disease: an updated meta-analysis
por: Chai, Bingyan, et al.
Publicado: (2019)

A Systematic Review and Meta-Analysis of Retinal Microvascular Features in Alzheimer's Disease
por: Jin, Qifang, et al.
Publicado: (2021)

Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease
por: Li, Dan-Dan, et al.
Publicado: (2019)

The potential diagnostic accuracy of urine formaldehyde levels in Alzheimer’s disease: A systematic review and meta-analysis
por: Chen, Fan, et al.
Publicado: (2022)

Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update
por: Jan, Arif Tasleem, et al.
Publicado: (2017)

Afferent and Efferent Visual Markers of Alzheimer’s Disease: A Review and Update in Early Stage Disease
por: Wu, Shirley Z., et al.
Publicado: (2020)

Matrix disequilibrium in Alzheimer’s disease and conditions that increase Alzheimer’s disease risk
por: Amontree, Matthew, et al.
Publicado: (2023)

Catecholamines in Alzheimer's Disease: A Systematic Review and Meta-Analysis
por: Pan, Xiongfeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_glssdpbh71k0m5lk14v0io9nfv